Literature DB >> 2740343

Comparison of the chromosomal localization of murine and human glucocerebrosidase genes and of the deduced amino acid sequences.

R R O'Neill1, T Tokoro, C A Kozak, R O Brady.   

Abstract

To study structure-function relationships and molecular evolution, we determined the nucleotide sequence and chromosomal location of the gene encoding murine glucocerebrosidase (glucosylceramidase; D-glucosyl-N-acylsphingosine glucohydrolase, EC 3.2.1.45). In the protein coding region of the murine cDNA, the nucleotide sequence and the corresponding deduced amino acid sequences were 82% and 86% identical to the respective human sequences. All five amino acids presently known to be essential for normal enzymatic activity were conserved between mouse and man. The murine enzyme had a single deletion relative to the human enzyme at amino acid number 273. One ATG translation initiation signal was present in the mouse sequence in contrast to the human sequence, where two start codons have been reported. Nucleotide sequencing of a clone derived from murine genomic DNA revealed that the murine signal for translation initiation was located in exon 2. The locations of all 10 introns were conserved among mouse and man. We mapped the genetic locus for glucocerebrosidase to mouse chromosome 3, at a position 7.6 +/- 3.2 centimorgans from the locus for the beta subunit of nerve growth factor. Comparison of linkage relationships in the human and murine genome indicates that these closely linked mouse genes are also syntenic on human chromosome 1 but in positions that span the centromere.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2740343      PMCID: PMC297554          DOI: 10.1073/pnas.86.13.5049

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.

Authors:  S Tsuji; P V Choudary; B M Martin; S Winfield; J A Barranger; E I Ginns
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

3.  Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA.

Authors:  J Sorge; C West; B Westwood; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.

Authors:  E I Ginns; P V Choudary; S Tsuji; B Martin; B Stubblefield; J Sawyer; J Hozier; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients.

Authors:  E H Kolodny; M D Ullman; H J Mankin; S S Raghavan; J Topol; J L Sullivan
Journal:  Prog Clin Biol Res       Date:  1982

6.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

7.  Structure of the N-asparagine-linked oligosaccharide units of human placental beta-glucocerebrosidase.

Authors:  S Takasaki; G J Murray; F S Furbish; R O Brady; J A Barranger; A Kobata
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.

Authors:  K Osiecki-Newman; D Fabbro; G Legler; R J Desnick; G A Grabowski
Journal:  Biochim Biophys Acta       Date:  1987-09-02

10.  Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.

Authors:  T Dinur; K M Osiecki; G Legler; S Gatt; R J Desnick; G A Grabowski
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more
  14 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Mouse chromosome 3.

Authors:  M H Meisler; J A Todd; N Rodrigues; E K Wakeland; M F Seldin
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  High level transcription of the glucocerebrosidase pseudogene in normal subjects and patients with Gaucher disease.

Authors:  J Sorge; E Gross; C West; E Beutler
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 4.  Mouse map of paralogous genes.

Authors:  J H Nadeau; M Kosowsky
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 5.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 6.  Mouse chromosome 3.

Authors:  M H Meisler; M F Seldin
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

7.  Y418C: a novel mutation in exon 9 of the glucocerebrosidase gene of a patient with Gaucher disease creates a new Bgl I site.

Authors:  R Tuteja; N Tuteja; F Lilliu; B Bembi; R Galanello; A Cao; F E Baralle
Journal:  Hum Genet       Date:  1994-09       Impact factor: 4.132

8.  Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher disease.

Authors:  P Bornstein; C E McKinney; M E LaMarca; S Winfield; T Shingu; S Devarayalu; H L Vos; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease.

Authors:  D P Germain; J P Puech; C Caillaud; A Kahn; L Poenaru
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

10.  Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease.

Authors:  You-Hai Xu; Brian Quinn; David Witte; Gregory A Grabowski
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.